Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Mar 8:6:1.
doi: 10.1186/s40734-019-0076-z. eCollection 2019.

Transcranial magnetic stimulation therapy for focal leg dystonia: a case report

Affiliations
Case Reports

Transcranial magnetic stimulation therapy for focal leg dystonia: a case report

Kush Sharma et al. J Clin Mov Disord. .

Abstract

Background: Dystonia is a debilitating disease that causes abnormal, often repetitive, movements, postures or both. The pathophysiology is unknown but related to loss of neuronal inhibition, aberrant sensorimotor integration, and/or derangements of synaptic plasticity. Current treatments include pharmacotherapy, botulinum toxin injections and deep brain stimulation (DBS). The response to these treatments are often limited and carry the risk of side effects requiring alternative therapies such as non-invasive brain stimulation.

Case presentation: We present a case report of a 65-year -old man with refractory focal 'task-specific' dystonia. The treatment plan included 10-daily sessions of 1 Hz, 2600 pulses of repetitive transcranial magnetic stimulation (rTMS) targeting the primary motor cortex.

Conclusion: There were no clinical benefits noticed. Currently, there are no rTMS protocol treatments for dystonia. Publication of negative results will help in refining the optimal stimulation parameters, thus maximizing the effectiveness and reproducibility of future therapeutic protocols.

Keywords: Dystonia therapy; Focal dystonia; Repetitive transcranial magnetic stimulation; Task-specific dystonia.

PubMed Disclaimer

Conflict of interest statement

The patient provided written consent for the TMS procedures as well as for the videotaping of the focal dystonia phenomenology.All authors reviewed and approved the final submission.The authors declare that they have no competing interests.Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Overview of rTMS procedures

References

    1. Albanese A, Bhatia K, Bressman SB, Delong MR, Fahn S, Fung VS, et al. Phenomenology and classification of dystonia: a consensus update. Mov Disord. 2013;28:863–873. doi: 10.1002/mds.25475. - DOI - PMC - PubMed
    1. Quartarone A, Ruge D. How many types of dystonia? Pathophysiological considerations. Front Neurol. 2018;9:12. doi: 10.3389/fneur.2018.00012. - DOI - PMC - PubMed
    1. Hallett M. Neurophysiology of dystonia: the role of inhibition. Neurobiol Dis. 2011;42:177–184. doi: 10.1016/j.nbd.2010.08.025. - DOI - PMC - PubMed
    1. Lozeron P, Poujois A, Richard A, Masmoudi S, Meppiel E, Woimant F, et al. Contribution of TMS and rTMS in the understanding of the pathophysiology and in the treatment of dystonia. Front Neural Circuits. 2016;10:90. doi: 10.3389/fncir.2016.00090. - DOI - PMC - PubMed
    1. Biagioni MC, Sharma K, Migdadi HA, Cucca A. Non-Invasive Neuromodulation Therapies for Parkinson’s Disease. IntechOpen. 2018. 10.5772/intechopen.75052.

Publication types

LinkOut - more resources